Pfizer seeks US approval to ease handling of COVID-19 vaccine
- Pfizer/BioNTech's vaccine, along with Moderna Inc's two-dose shot, won the US emergency use authorization (EUA) and is being widely distributed as part of the country's mass vaccination efforts.
- The data submitted may facilitate the handling of our vaccine in pharmacies and provide vaccination centers an even greater flexibility.